✦ LIBER ✦

Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II study

✍ Scribed by Takumi Kawaguchi, Atsumasa Komori, Masataka Seike, Shigetoshi Fujiyama, Hiroshi Watanabe, Masatoshi Tanaka, Shotaro Sakisaka, Makoto Nakamuta, Yutaka Sasaki, Makoto Oketani, Toshihiro Hattori, Koichi Katsura, Michio Sata

Book ID: 118787603
Publisher: Springer Japan
Year: 2012
Tongue: English
Weight: 324 KB
Volume: 47
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-012-0600-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of entecavir versus

Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study

✍ Yun-Fan Liaw; Maria Raptopoulou-Gigi; Hugo Cheinquer; Shiv Kumar Sarin; Tawesak 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB 👁 2 views

A randomized, open-label comparative study of entecavir versus adefovir therapy was performed in subjects with chronic hepatitis B who had hepatic decompensation (Child-Turcotte-Pugh score ≥7). Adult subjects were randomized and treated (n = 191) with entecavir 1.0 mg or adefovir 10 mg daily for up

Safety and efficacy of sunitinib in pati

Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study

✍ Sandrine Faivre; Eric Raymond; Eveline Boucher; Jean Douillard; Ho Y Lim; Jun S 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 178 KB

Adalimumab in Japanese patients with mod

Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results from a Phase II/III randomized controlled study

✍ Akihiko ASAHINA; Hidemi NAKAGAWA; Takafumi ETOH; Mamitaro OHTSUKI; THE ADALIMUMA 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 490 KB

Efficacy and safety of calcium dobesilat

Efficacy and safety of calcium dobesilate in patients with chronic venous insufficiency: an open-label, multicenter study

✍ Fiorenzo Angehrn 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 482 KB

The efficacy and safety of degarelix: a

The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer

✍ Laurence Klotz; Laurent Boccon-Gibod; Neal D. Shore; Cal Andreou; Bo-Eric Persso 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB

A 2-year comparative open label randomiz

A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis

✍ Anna Rita Giardina; Angelo Ferrante; Francesco Ciccia; Rosalia Impastato; Maria 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 239 KB